Corcept Therapeutics Incorporated
CORT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $761M | $675M | +12.8% |
| Operating income | $44.8M | $137M | −67.3% |
| Net income | $98.2M | $140M | −29.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $340M | $208M | +64.0% |
| Operating income | $115M | $10.2M | +1,025% |
| Net income | $127M | $19.7M | +544% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Corcept's revenue in FY2025?
- $761M in FY2025 (Fiscal year ended Dec 31, 2025), +12.8% vs $675M a year earlier, per its 10-K filed Feb 2026.
- Was Corcept profitable in FY2025?
- Yes: net income was $98.2M and operating income $44.8M in FY2025.
- What was Corcept's revenue in Q3 2026?
- $340M (+64.0% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.